
Academic Journal
Q4Allergologie
About Allergologie
Allergologie — Full Profile
Allergologie is a German-language, peer-reviewed medical journal devoted to allergology and clinical immunology, published in Germany by Dustri-Verlag Dr. Karl Feistle. The JournalsWorld record for this post is anchored to its print ISSN, 0344-5062, and the journal has been published since 1978 — its publisher's online archive runs from Jahrgang (volume) 1 of 1978 to Jahrgang 49 of 2026, a span that makes it one of the long-standing specialist journals of German-language allergy medicine. Allergologie serves the physicians who diagnose and treat allergic disease in the German-speaking world: allergologists in clinic and practice, and the dermatologists, pulmonologists, paediatricians, ENT specialists and general practitioners whose daily work crosses into allergy. Its pages carry original work, reviews, guideline-related material and practice-oriented continuing education on allergic rhinitis and sensitisation, asthma and respiratory disease, food allergy and anaphylaxis, skin disease and drug hypersensitivity — the topic profile that OpenAlex's analysis of the journal's content independently confirms. This profile is built from the publisher's own journal platform, from OpenAlex resolved through the journal's ISSN, from a Directory of Open Access Journals search and from SCImago-derived secondary listings, and it states plainly the points that could not be verified from those sources. One naming point must be made at the outset, because it decides how this record should be read: Allergologie also has an English-language companion title from the same publisher, a separate journal with its own ISSN (2512-8957) and its own JournalsWorld record (post 12611). The two titles are related but they are not the same journal, they do not share an ISSN, and this profile is about the German-language Allergologie alone.
Identity at a Glance
| Title | Allergologie |
|---|---|
| Print ISSN | 0344-5062 |
| Publisher | Dustri-Verlag Dr. Karl Feistle, Germany |
| Country | Germany |
| First published | 1978 (volume 1); archive verified on the publisher's platform through volume 49 (2026) |
| Language | German |
| Field | Allergology and clinical immunology |
| Access model | Subscription journal with an online edition on the publisher's platform; not an open access journal in the OpenAlex and DOAJ evidence checked |
| Companion title | A separate English-language companion journal from the same publisher, ISSN 2512-8957, held on this site as post 12611 — a distinct record, not a duplicate of this one |
The stored JournalsWorld record previously described the publisher with a numeric code rather than a name and quoted an h-index without a source; both points are corrected below from named sources and listed again in the Sources and Verification section. The journal's own platform is Dustri Online Services, where the Allergologie pages carry the current issue, the full archive, aims and scope, publishing policies, publication fee information, instructions for authors, an online submission route, the editorial board and subscription information — the standard furniture of a publisher-run medical journal, maintained by the publisher itself.
History and Development
Allergologie began in 1978, and the publisher's archive — which lists every Jahrgang from volume 1 (1978) forward, with monthly issues visible in recent volumes such as volume 49 (2026), whose issues run month by month through the year — is the most direct evidence of an unbroken publishing life of nearly five decades. The journal grew up with German allergology as an organised specialty: the decades in which allergy became a defined additional qualification in German medicine, in which the German Society for Allergology and Clinical Immunology (DGAKI) and the Association of German Allergologists (AeDA) developed the guideline culture that still structures German allergy practice, and in which diagnostic and therapeutic practice moved from skin testing and hyposensitisation in their classical forms toward component-resolved diagnostics, biologics and standardised allergen immunotherapy. A journal that has appeared continuously through that whole period, in the language its practitioners read, occupies a particular niche: it is where German allergy medicine talks to itself — about guidelines and their local application, about the reimbursement and regulatory conditions of German practice, about training and about the cases and studies produced in German clinics.
The publisher matters to that identity. Dustri-Verlag Dr. Karl Feistle is a German medical publisher whose list is built around German-language specialist journals, and Allergologie sits on its platform alongside the publisher's other German titles. The journal's development in the online era has followed the platform pattern: a complete digital archive reaching back to 1978, article-level online reading, an online submission route, and the English-language companion title, launched to carry a chosen set of the journal's content — in English — to readers outside the German-speaking world. That companion is recorded on the publisher's site as a distinct journal entry in its own right, and reference databases treat it as one: it has its own ISSN and its own citation record. Nothing in the verified evidence suggests the German journal was renamed, replaced or continued by the companion; the two run in parallel, and the correct cataloguing treatment — the treatment this profile follows — is two records, two ISSNs, one documented relationship.
OpenAlex's record for the journal, resolved through the print ISSN, gives the same long arc in numbers: a first publication year of 1978 and content continuing into 2026, with 2,332 works indexed across that span. For a national-language specialist journal, that archive depth is the point. German allergology's older literature — the decades in which its guidelines, its diagnostic traditions and many of its standard references were formed — is substantially written in this journal, and it remains reachable through the publisher's archive.
Scope and Subject Coverage
Allergologie covers allergology and clinical immunology as they are practised. OpenAlex's topic analysis of the journal's published content, fetched for this profile, names its dominant topics as allergic rhinitis and sensitisation; asthma and respiratory diseases; food allergy and anaphylaxis research; dermatology and skin diseases; and drug-induced adverse reactions. Read together, those five topics describe the working map of German allergy practice with unusual accuracy. Rhinitis and sensitisation cover the diagnostic heart of the field — skin prick and intracutaneous testing, specific IgE and its component-resolved successors, provocation testing and the interpretation of sensitisation against clinical relevance. Asthma and respiratory disease bring in the airway half of the specialty, where allergology overlaps with pulmonology. Food allergy and anaphylaxis cover the field's highest-stakes presentations and its emergency guidance. Dermatology reflects the large share of German allergologists whose home specialty is skin — contact allergy, atopic eczema, urticaria and occupational skin disease are standing Allergologie territory. Drug hypersensitivity, finally, is one of the areas in which German centres have produced influential diagnostic guidance, and it appears in the journal accordingly.
Around those clinical topics sits the journal's practice layer. Allergologie is a journal for a national professional community, so guideline presentations and commentary, society business of the German allergy societies, continuing-education material, and discussion of the German regulatory and reimbursement environment for diagnostics and allergen products all belong in its pages in a way they would not in an international research journal. The article fetched during research for this profile — a discussion of whether authorised allergen products for intracutaneous testing might cease to be obtainable in Germany under European legislation, written by authors from the German allergy societies together with staff of the Paul-Ehrlich-Institut, Germany's federal institute for vaccines and biomedicines — is a fair example of the genre: a topic of no less scientific seriousness for being specific to German and European practice, and one that an English-language international journal would be unlikely to carry at the same length or with the same audience in mind. Authors should judge fit by that standard: work whose natural readership is the German-speaking allergy community, whether the work is a study, a review or a practice-shaping guideline discussion, is Allergologie material; work aimed at the international basic-immunology audience generally is not.
Editorial Board and Governance
Allergologie is a publisher's journal: it is owned and run through Dustri-Verlag's journal operation, and its platform maintains the standard governance pages — an editorial board page, named contact points for the publisher, the managing editor and the editor-in-chief, publishing policies and instructions for authors. The names of the current editor-in-chief and board members could not be verified from the platform pages fetched for this profile — the publisher's site structure confirms that those pages exist and are maintained, but the fetched views did not expose the names — and this profile therefore does not supply names from memory or from third-party listings that could not be checked. Authors who need the masthead should read it on the journal's pages at Dustri Online Services, where it is current by definition. That restraint is deliberate and follows the rule applied across this profile: a named person is a checkable fact, and an uncheckable one is left unstated rather than guessed.
What can be described on the evidence is the governance shape, which is typical of German society-adjacent specialist publishing: a publisher-run journal with an academic editor-in-chief and board drawn from the specialty, in a field whose learned societies — DGAKI and AeDA among them — set the guideline agenda that the journal then discusses, presents and applies. The journal's content record shows that relationship in practice, with society guideline authors and federal-institute experts publishing in its pages. For a submitting author, the practical meaning is that editorial judgement in Allergologie is exercised with German clinical practice in view: a manuscript is assessed not only for scientific soundness but for what it changes, confirms or clarifies for the physicians who will read it.
Peer Review and Editorial Process
Allergologie is a peer-reviewed journal — the stored record describes it as such, the publisher presents it among its peer-reviewed medical titles, and its content is indexed as a peer-reviewed journal in the scholarly databases that carry it. The publisher's platform provides the operational machinery of a modern editorial process: instructions for authors, an online submission route ("Submit Article Online" in the journal's own navigation), publishing policies and a publication-fees page. The specific review model — the number of reviewers, whether review is anonymised in one direction or both, and average turnaround times — could not be verified from the pages fetched for this profile, and no figures for acceptance rates or decision times are stated here, because none could be checked against a publisher source. Authors preparing a submission should work from the journal's current instructions for authors on the Dustri platform, which govern format, language and article categories as the editorial office applies them, rather than from any secondary summary — including, on those operational details, this one.
Manuscripts are in German. That single fact organises most submission decisions: a research group outside the German-speaking world that wants its work in Allergologie needs a German-language manuscript of publishable quality, and the journal's English-language companion exists precisely as the alternative route for content the publisher wishes to place before an international readership. Within the journal itself, the editorial process sorts submissions in the way German specialist journals conventionally do — original articles, reviews and overview pieces, guideline and consensus material, case-based and practice-oriented contributions, and continuing-education content — each judged against the expectations of a clinician readership that will apply what it reads.
Article Types
The journal's article mix can be read from its archive and its topic profile. Original articles report clinical and laboratory studies from allergy practice and research — diagnostic comparisons, treatment and immunotherapy outcomes, epidemiology of allergic disease in German-speaking populations. Review and overview articles synthesise a defined clinical problem for the practising reader. Guideline and consensus contributions present, adapt or comment on the recommendations of the German allergy societies and their partners, a category of unusual weight in German medicine, where the S-classified guideline system structures everyday care. Case reports and practice pieces carry the single-patient and small-series material from which much clinical allergy learning comes. Continuing-education contributions serve the certified training needs of German physicians. Society communications and professional-policy articles — on the availability of diagnostic allergens, on reimbursement, on training requirements — complete a mix that is deliberately broader than a pure research journal's, because the journal functions as the specialty's own periodical and not only as an archive of studies.
Open Access, Licensing and Charges
Allergologie is not an open access journal on the evidence checked for this profile. OpenAlex records the source as not open access; a search of the Directory of Open Access Journals by the journal's ISSN returned no listing at the time of checking; and the publisher's platform presents the journal with subscription information and a subscription plan, alongside free-sample and voucher routes of the kind subscription publishers use. Individual articles are read online through the publisher's platform under its terms, and the English-language companion title operates under its own arrangements, which are stated on that title's own pages. The publisher's Allergologie navigation includes a publication-fees page, which shows that fee information is a maintained part of the journal's public information; the actual fee amounts could not be verified from the pages fetched for this profile, and no figure is quoted here. Authors should read the current fees page and the instructions for authors on the Dustri platform before submitting, and should not carry over fee assumptions from other journals — German subscription journals' page-charge and colour-charge traditions differ from publisher to publisher and change over time.
Preservation and Identifiers
The journal's anchor identifier is its print ISSN, 0344-5062, the ISSN-L for the title and the identifier under which OpenAlex resolves it. Articles in the journal's modern file carry DOIs in the publisher's 10.5414 series, visible on the article records that reference databases expose for Allergologie content. Preservation of the journal's archive is, on the evidence, publisher-held: Dustri Online Services presents a complete run from volume 1 (1978) to the current volume, readable online at article level, which is the form in which most readers and libraries now reach the back file. No additional third-party preservation arrangement could be verified from the sources fetched, and none is claimed here. The companion English-language title has its own ISSN, 2512-8957, and must be cited and catalogued under that identifier, never under 0344-5062; confusing the two is the single most likely cataloguing error with this journal family, and it is the error this profile is most concerned to prevent.
Indexing and Discoverability
Allergologie is indexed in Scopus, on which the SCImago indicators below are based, and its content is aggregated by OpenAlex, which resolves the title by ISSN and supplies the work and citation counts used in this profile. Its subject home in the SCImago classification is the Immunology and Allergy category, where the journal sits in the fourth quartile — the expected position for a national-language practice journal in a category headed by international English-language titles, and a position that says more about the category's language structure than about the journal's standing with its own readers. Discoverability outside the German-speaking world runs substantially through the English-language companion title, whose articles are the version of the journal family's content that international readers, and the reference databases they use, most often meet. Authors and evaluators should therefore be careful, when they search for this journal's output, to search both titles and both ISSNs, and to keep the two result sets apart when counting.
Metrics and Standing
OpenAlex, fetched directly for this profile through the ISSN endpoint, records Allergologie with 2,332 works and 2,436 citations across its run from 1978 to the present, an h-index of 16, an i10-index of 50 and a two-year mean citedness of about 0.09. SCImago's ranking for the Immunology and Allergy category, in the round reproduced by the SCImago site itself, places Allergologie at an SJR of 0.208 in the fourth quartile, with 85 documents counted for 2025. The stored JournalsWorld record previously quoted an h-index of 20 without a source; the sourced figures are the two just given — 16 in OpenAlex at the time of checking, and the SCImago series behind the 0.208 SJR — and they differ because the databases count different citation universes over different windows. None of these numbers measures what the journal is actually for. Allergologie's standing is professional rather than bibliometric: it is the standing German-language periodical of its specialty, read by the clinicians who deliver allergy care in Germany, Austria and Switzerland, carrying their guidelines debate, their regulatory discussion and their clinical literature in their working language. A low international citation rate is the predictable shadow of that role, not a refutation of it, and evaluators who apply international research-journal metrics to a national practice journal will misunderstand both the journal and the metrics.
How to Submit
Submissions run through the publisher's platform: the journal's pages at Dustri Online Services carry a "Submit Article Online" route and an instructions-for-authors page, and those two pages are the authoritative route and rulebook for a manuscript. Before submitting, an author should settle four questions. Is the manuscript in German of publishable quality? Is its natural audience the German-speaking allergy community — clinicians who will use it — rather than the international immunology research audience? Does it follow the journal's current instructions on format, article category and declarations? And is any fee position clear from the publisher's current publication-fees page? A manuscript that answers those four questions well is the kind Allergologie exists to publish. Authors whose work is aimed at an international English-language readership should consider the companion title or another English-language allergy journal instead, and should discuss the choice with the editorial office if the work has a specific reason to appear in the German journal — for example, because it comments on a German guideline or a German regulatory question, which are precisely the topics for which Allergologie is the natural and sometimes the only suitable home.
Readership and Fit
The readership is the German-speaking allergy profession: specialists in allergology and in the neighbouring fields that feed it — dermatology, pulmonology, paediatrics, ENT and internal medicine — together with the trainees working toward the allergy qualification and the researchers in German allergy centres who write for them. The journal fits original clinical studies, reviews, guideline work and practice contributions addressed to that readership. It does not fit basic immunology without clinical application, work whose context is a different health system presented without reference to German practice, or manuscripts their authors are unwilling to publish in German. Understanding that fit honestly is a service to authors: a good paper sent to the wrong-language, wrong-audience journal costs its authors a year; the same paper sent to the journal whose readers need it becomes part of a specialty's working literature.
Related Journals Readers Also Consult
Readers of this profile frequently also consult the JournalsWorld record for the journal's English-language companion title (post 12611, ISSN 2512-8957), a separate record for a separate journal from the same publisher, linked to this one in the way described above; the profile of Allergo Journal (post 333785), Springer Medizin's German-language allergy journal, which covers neighbouring ground for a neighbouring readership under different ownership; and the profile of hautnah dermatologie (post 335271), whose dermatology readership overlaps with the allergy community. None of these records is a duplicate of Allergologie: each carries its own ISSNs, verified in the twin check for this post, and no other record on this site carries ISSN 0344-5062.
Frequently Asked Questions
What is Allergologie's ISSN? The print ISSN is 0344-5062. The English-language companion title has a different ISSN, 2512-8957, and its own record.
Who publishes Allergologie? Dustri-Verlag Dr. Karl Feistle in Germany. The stored record's numeric publisher code is not a name and should be read as corrected here.
Since when has Allergologie been published? Since 1978. The publisher's archive runs from volume 1 (1978) to volume 49 (2026).
In what language does Allergologie publish? German. Authors who need an English-language outlet should consider the publisher's English-language companion title.
Is Allergologie open access? No listing was found in the Directory of Open Access Journals at the time of checking, OpenAlex records the journal as not open access, and the publisher presents it with subscription arrangements — it is a subscription journal with online reading through the publisher's platform.
Is Allergologie the same journal as its English-language companion? No. The companion is a separate journal with its own ISSN and its own JournalsWorld record (post 12611). The titles are related — same publisher, a chosen set of content in English — but they are catalogued, cited and counted separately.
What are Allergologie's metrics? OpenAlex, at the time of checking, recorded 2,332 works, 2,436 citations and an h-index of 16; SCImago places the journal at SJR 0.208, fourth quartile, in Immunology and Allergy. Quote figures with their source.
Does Allergologie charge authors? The publisher maintains a publication-fees page for the journal, but the amounts could not be verified from the pages fetched for this profile. Read the current page on the Dustri platform before submitting.
Sources and Verification
Sources fetched for this profile: the JournalsWorld REST record for post 27806 (identity, thin stored content, stored ISSN 0344-5062); the twin check saved as twincheck-27806.txt, covering REST searches by ISSN in hyphenated and unhyphenated form, title searches, slug lookups and supplemental searches, all read in full — no other record carries this journal's ISSN, and the English-language companion (post 12611, ISSN 2512-8957, thin) was verified as a distinct title rather than a twin; the publisher's platform, Dustri Online Services, whose Allergologie pages show the archive from volume 1 (1978) to volume 49 (2026) and the journal's aims, policies, fees, instructions, submission, editorial-board and subscription pages; OpenAlex source record resolved through the ISSN endpoint (S131891354: works, citations, h-index, i10-index, mean citedness, topic profile, first and last publication years); a DOAJ search by ISSN, which returned no listing; and SCImago's Immunology and Allergy category ranking as published on the SCImago site (SJR 0.208, Q4, 85 documents for 2025). Corrections to the stored record: the stored publisher value was a numeric code, not Dustri-Verlag's name; and the stored h-index of 20 was unsourced — sourced figures are given in the Metrics section. Fields that could not be verified — the current named editor-in-chief and board, fee amounts, and the detailed review model and turnaround times — are stated as not verified in the body of this profile rather than filled in from guesswork.
Source-backed journal facts
Topics in published research
Allergic Rhinitis and Sensitization; Food Allergy and Anaphylaxis Research; Contact Dermatitis and Allergies; Asthma and respiratory diseases; Health and Medical Studies; Dermatology and Skin Diseases.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-09-30. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Dupilumab zur Therapie der Erdnussallergie – Prävention der Erdnussallergie durch Händewaschen – Mastozytose: Risiko für schwere Stichreaktionen – Multiple nsLTPs Sensibilisierungen und Bestimmung relativer IgE-Dominanzen
2026-10-01 · DOI: 10.5414/alp49525Dupilumab verbessert die langfristige Asthmakontrolle bei deutschen Patienten mit schwerem Asthma: Daten aus der Praxis
A. Renner, S. Stoshikj, E. Hamelmann, D. Skowasch et al.
2026-10-01 · DOI: 10.5414/alx02646Künstliche Intelligenz in der Allergologie: Ein Positionspapier der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI), des Ärzteverbands Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für Pädi
O. Pfaar, S. Traidl, F. Bärhold, S. Becker et al.
2026-10-01 · DOI: 10.5414/alx02655Bettina Wedi – zum 60. Geburtstag
2026-10-01 · DOI: 10.5414/alp49588Künstliche Intelligenz in der Allergologie: Ein Positionspapier der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI), des Ärzteverbands Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für Pädi
O. Pfaar, S. Traidl, F. Bärhold, S. Becker et al.
2026-10-01 · DOI: 10.5414/alx02643Junior Member stellen sich vor: Lea Faust
2026-10-01 · DOI: 10.5414/alp49590Einladung zur DGAKI-Frühjahrstagung
2026-10-01 · DOI: 10.5414/alp49592Editorial: Künstliche Intelligenz in der Allergologie: Neugier ja, Blindflug nein
A. Zink
2026-10-01 · DOI: 10.5414/alx02658Neue S2k-Leitlinie – Allergologie Select weiterhin in den TOP 10 der allergologischen Fachzeitschriften – Abstracts vom DAK
M. Raulf, T. Werfel
2026-09-01 · DOI: 10.5414/alx02656Bedeutung von Api g 7 bei schwerer Sellerieallergie – Klinische Symptome beim Lipidtransferproteine-Syndrom – α-Gal-IgE und Erstinfusionreaktionen und Allergenität von Ustekinumab – Serinprotease-like protein B SplB aus Staphy
2026-09-01 · DOI: 10.5414/alp4943521. Deutscher Allergiekongress; 1. – 3. Oktober 2026, Wiesbaden
Sven Becker, Ludger Klimek
2026-09-01 · DOI: 10.5414/alx02649S2k-Leitlinie – Standardisierte Durchführung des nasalen und konjunktivalen Provokationstests bei allergischen Erkrankungen der oberen Atemwege
U. Förster-Ruhrmann, T. Ankermann, S. Becker, P. Bubel et al.
2026-09-01 · DOI: 10.5414/alx02647Wir stellen uns vor: Allergiezentrum Nord-West (AZNW) am Universitätsklinikum Münster
I. Lesmann, I. Nierkamp, R. Gellner, R. Hasseli-Fräbel et al.
2026-09-01 · DOI: 10.5414/alx02650Allergien gegen asiatische Hornisse – Präventive SLIT bei sensibilisierten Vorschulkindern – IgG4-Antworten auf dominante Hymenopterengiftallergene bei Venom-Immuntherapie und natürlicher Exposition – Allergenverkapselte Nanopa
2026-08-01 · DOI: 10.5414/alp49381Auswahl und Wechsel von Biologika bei Patienten mit schwerem Asthma – Real- World-Daten aus dem German Asthma Net (GAN)
A. Lenoir, R. Buhl, C. Muemmler, J. Behr et al.
2026-08-01 · DOI: 10.5414/alx02636Arzneimittelüberempfindlichkeiten
K. Brockow†, R. Treudler, I. Neustädter
2026-08-01 · DOI: 10.5414/alp49422Der MRGPRX2-Paradigmenwechsel: Neudefinition der Mastzellaktivierungswege bei chronischer Urtikaria
K. Wu, J. Liu
2026-08-01 · DOI: 10.5414/alx02618Lässt sich anhand des Teicoplanin-Hauttests eine IgE-vermittelte Überempfindlichkeit vorhersagen?
N.B. BaÅtuÄ Ä°nan, Ö. Göktürk, Y. Karahan, K. Aksu et al.
2026-08-01 · DOI: 10.5414/alx02632Rückblick auf die 5. Sitzung des DGfI-Arbeitskreises für Allergologie und Immunologie
2026-08-01 · DOI: 10.5414/alp49431Kontaktallergische Reaktion auf Titanport: Diagnostische Herausforderungen und klinische Herangehensweise
S. Fugger, A. Kaufmann, H. Dickel
2026-07-01 · DOI: 10.5414/alx02637Reviews
Community Reviews
Version History
October 26, 2026 at 6:45 am
October 2, 2026